Prochaska, Jürgen H.
Göbel, Sebastian
Nagler, Markus
Knöpfler, Torben
Eggebrecht, Lisa
Lamparter, Heidrun
Panova-Noeva, Marina
Keller, Karsten
Coldewey, Meike
Bickel, Christoph
Lauterbach, Michael
Hardt, Roland
Espinola-Klein, Christine
ten Cate, Hugo
Rostock, Thomas
Münzel, Thomas
Wild, Philipp S.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure
https://doi.org/10.1007/s00392-018-1293-4
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (BMBF 10E01003)
Boehringer Ingelheim Pharma GmbH & Co. KG
Bayer Vital GmbH
Daiichi Sankyo Europe GmbH
Sanofi-Aventis Germany GmbH
IMO Institute GmbH
Portavita BV
Deutsche Herzstiftung
Center for Translational Vascular Biology (CTVB) of the University Medical Center Mainz
Article History
Received: 10 January 2018
Accepted: 5 June 2018
First Online: 9 June 2018
Compliance with ethical standards
:
: There are no conflicts of interest to declare.